Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Reducing Timelines for Vaccine Potency Testing

Shortening the vaccine development cycle by reducing the need for costly, time-consuming manual analyses of vaccine potency is allowing pharma and biotech companies to increase their throughput. Using this strategy, automation can help to ensure that the most effective vaccines reach the market more rapidly.

By Martin Smith at Synbiosis (March 2010)

Keywords: timelines, vaccine, potency, testing, cycle, market, rapidly, development, bacterial, viral, automated counting technology

    View full article    |    Back to Biopharma section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |